|Chemical and physical data|
|Molar mass||437.43543 g/mol|
|3D model (Jmol)||Interactive image|
Acetothiolutamide is a selective androgen receptor modulator (SARM) derived from the non-steroidal antiandrogen bicalutamide that was described in 2002 and was one of the first SARMs to be discovered and developed. It is a high-affinity, selective ligand of the androgen receptor (AR) (Ki = 2.1–4.9 nM), where it acts as a full agonist in vitro, and has in vitro potency comparable to that of testosterone. However, in vivo, acetothiolutamide displayed overall negligible androgenic effects, though significant (albeit very low) anabolic effects were observed at high doses. In addition, notable antiandrogen effects were observed in castrated male rats treated with testosterone propionate. The discrepancy between the in vitro and in vivo actions of acetothiolutamide was determined to be related to rapid plasma clearance and extensive hepatic metabolism into a variety of metabolites with differing pharmacological activity, including AR partial agonism and antagonism. In accordance with its poor metabolic stability, acetothiolutamide is not orally bioavailable, and shows activity only via injected routes such as subcutaneous and intravenous.
- Dalton, James T.; Mukherjee, Arnab; Zhu, Zixin; Kirkovsky, Leonid; Miller, Duane D. (1998). "Discovery of Nonsteroidal Androgens". Biochemical and Biophysical Research Communications. 244 (1): 1–4. doi:10.1006/bbrc.1998.8209. ISSN 0006-291X.
- Yin, D. (2002). "Pharmacology, Pharmacokinetics, and Metabolism of Acetothiolutamide, a Novel Nonsteroidal Agonist for the Androgen Receptor". Journal of Pharmacology and Experimental Therapeutics. 304 (3): 1323–1333. doi:10.1124/jpet.102.040832. ISSN 0022-3565.
- Jeffrey Dale Kearbey (2004), Preclinical Pharmacokinetics and Skeletal Pharmacology of a Selective Androgen Receptor Modulator
- Perera, M. A. (2006). "In Vivo Metabolism and Final Disposition of a Novel Nonsteroidal Androgen in Rats and Dogs". Drug Metabolism and Disposition. 34 (10): 1713–1721. doi:10.1124/dmd.106.009985. ISSN 0090-9556.
- Kim, J. (2005). "The Para Substituent of S-3-(Phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides Is a Major Structural Determinant of in Vivo Disposition and Activity of Selective Androgen Receptor Modulators". Journal of Pharmacology and Experimental Therapeutics. 315 (1): 230–239. doi:10.1124/jpet.105.088344. ISSN 0022-3565.
- Yin, D. (2002). "Pharmacodynamics of Selective Androgen Receptor Modulators". Journal of Pharmacology and Experimental Therapeutics. 304 (3): 1334–1340. doi:10.1124/jpet.102.040840. ISSN 0022-3565.